Teicoplanin Mylan New Zealand - English - Medsafe (Medicines Safety Authority)

teicoplanin mylan

viatris limited - teicoplanin 400mg - powder for injection - 400 mg - active: teicoplanin 400mg excipient: sodium chloride sodium hydroxide - teicoplanin mylan is indicated in adults and in children from 2 months for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents including beta-lactam antibiotics: bone - osteomyelitis

TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

teicoplanin sandoz teicoplanin 400mg powder for injection vial with diluent ampoule

sandoz pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - teicoplanin sandoz is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (non-cardiac bacteraemia, septicaemia).

Teicoplanin 400 mg powder and solvent for solution for injection/infusion or oral solution Malta - English - Medicines Authority

teicoplanin 400 mg powder and solvent for solution for injection/infusion or oral solution

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - teicoplanin - powder and solvent for solution for infusion or injection oral solution - teicoplanin 400 mg - antibacterials for systemic use

Teicoplanine Altan Pharma 400 mg inj./inf. sol. (pwdr. + solv.)/or. sol. (pwdr. + solv.) i.v./i.m. vial + amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teicoplanine altan pharma 400 mg inj./inf. sol. (pwdr. + solv.)/or. sol. (pwdr. + solv.) i.v./i.m. vial + amp.

altan pharma ltd. - teicoplanin 400 mg - powder and solvent for solution for injection/infusion; powder and solvent for oral solution - 400 mg - teicoplanin 400 mg - teicoplanin

Teicoplanin Bradex 400 mg inj./inf. sol. (pwdr. + solv.)/or. sol. i.v./i.m. vial + amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teicoplanin bradex 400 mg inj./inf. sol. (pwdr. + solv.)/or. sol. i.v./i.m. vial + amp.

bradex s.a. - teicoplanin 400 mg - powder and solvent for solution for injection/infusion; oral solution - 400 mg - teicoplanin 400 mg - teicoplanin

Targocid 400 mg or. sol. (pwdr. + solv.)/inf. sol. (pwdr. + solv.)/inj. sol. (pwdr. + solv.) i.m./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targocid 400 mg or. sol. (pwdr. + solv.)/inf. sol. (pwdr. + solv.)/inj. sol. (pwdr. + solv.) i.m./i.v. vial

sanofi belgium sa-nv - teicoplanin 400 mg - powder and solvent for solution for injection; powder and solvent for solution for infusion; powder and solvent for oral solution - 400 mg - teicoplanin 400 mg - teicoplanin

Teicoplanin 400 mg Powder and Solvent for Solution for injection/infusion or oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

teicoplanin 400 mg powder and solvent for solution for injection/infusion or oral solution

noridem enterprises limited - teicoplanin - powder and solvent for solution for injection/infusion - 400 milligram(s) - glycopeptide antibacterials; teicoplanin - glycopeptide antibacterials - it is indicated in adults and in children from birth for the parenteral treatment of the following infections: complicated skin and soft tissue infections; bone and joint infections; hospital acquired pneumonia; community acquired pneumonia; complicated urinary tract infections; infective endocarditis; peritonitis associated with continuous ambulatory peritoneal dialysis (capd) · bacteraemia that occurs in association with any of the indications listed above; also indicated as an alternative oral treatment for clostridium difficile infection- associated diarrhoea and colitis

Teicoplanin 400mg Powder and Solvent for solution for injection/infusion or oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

teicoplanin 400mg powder and solvent for solution for injection/infusion or oral solution

rowex ltd - teicoplanin - powder and solvent for solution for injection/infusion - 400 milligram(s) - glycopeptide antibacterials; teicoplanin - glycopeptide antibacterials - complicated skin and soft tissue infections, bone and joint infections, hospital acquired pneumonia, community acquired pneumonia, • complicated urinary tract infections, infective endocarditis, peritonitis associated with continuous ambulatory peritoneal dialysis (capd)

Teicoplanin Multichem New Zealand - English - Medsafe (Medicines Safety Authority)

teicoplanin multichem

multichem nz limited - teicoplanin 400mg equivalent to nlt 400,000 iu. 10% overage included. - powder for injection with diluent - 400 mg - active: teicoplanin 400mg equivalent to nlt 400,000 iu. 10% overage included. excipient: sodium chloride sodium hydroxide water for injection - teicoplanin multichem is indicated in adults and in children from 2 months for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents including beta-lactam antibiotics:- bone - osteomyelitis

Targocid New Zealand - English - Medsafe (Medicines Safety Authority)

targocid

pharmacy retailing (nz) ltd t/a healthcare logistics - teicoplanin 400mg - powder for injection with diluent - 400 mg - active: teicoplanin 400mg excipient: sodium chloride sodium hydroxide water for injection